- Home
- TWST vs XENE Comparison
TWST vs XENE Comparison
Compare TWST & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWST | XENE |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 3.4B |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TWST | XENE |
|---|---|---|
| Price | $30.92 | $44.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | $46.33 | ★ $53.91 |
| AVG Volume (30 Days) | ★ 1.7M | 768.3K |
| Earning Date | 11-14-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $376,572,000.00 | $7,500,000.00 |
| Revenue This Year | $15.19 | N/A |
| Revenue Next Year | $15.10 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.32 | N/A |
| 52 Week Low | $23.30 | $26.74 |
| 52 Week High | $55.33 | $46.60 |
Technical Indicators
Market Signals| Indicator | TWST | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 50.53 | 59.21 |
| Support Level | $31.19 | $42.89 |
| Resistance Level | $33.31 | $46.60 |
| Average True Range (ATR) | 1.66 | 1.46 |
| MACD | 0.20 | -0.03 |
| Stochastic Oscillator | 52.18 | 57.89 |
Price Performance
Historical ComparisonAbout TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.